FDA approves nasal spray device to treat seizures

The FDA Dec. 10 approved a device from Chicago-based devicemaker AptarGroup that uses a nasal spray to treat seizures, according to Medical Device Network

The device, called the unidose liquid system, is the first and only nasal treatment for patients with epilepsy. A plunger on the bottom of the device releases a drug into a patients' nostril, which is quickly absorbed by the nasal mucosa. 

The device can be used during or after a seizure and can be administered by people who are not healthcare professionals. Aptar's subsidiary, Noble International, made a training device to teach caregivers how to use the system. 

Read the full article here.

More articles on supply chain:
Walgreens, Kroger form GPO
Abbott warns of 2 potential safety issues with its heart implant
Edwards Lifesciences predicts $5B in revenue in 2020

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers